Sundus Khuder
Dibba Al-Fujairah Hospital, UAE.
Title: New approach and management of persistent pulmonary hypertension in newborn
Biography
Biography: Sundus Khuder
Abstract
Pulmonary hypertension (PH) is a life-threatening condition in newborns characterized by high blood pressure in the arteries of the lungs. It can lead to significant morbidity and mortality if not managed appropriately. The approach to managing newborns with PH involves a thorough evaluation of the underlying cause and severity of the disease. Early recognition and diagnosis are crucial for prompt intervention and improved outcomes. The role of three help us to understand and manage pphn much better There are three causes of pphn, there are three molecule pathways affect the pulmonary vessels, there are three types of management depend in the etiology and there are three echocardiography findings. In general, management strategies for PH in newborns aim to improve oxygenation, reduce pulmonary vascular resistance, and enhance cardiac function. Initial management includes supportive care measures such as supplemental oxygen, mechanical ventilation, and inotropic support. In addition, pharmacologic interventions such as inhaled nitric oxide, prostaglandins, and sildenafil may be used to reduce pulmonary vascular resistance and improve oxygenation. However, the use of these agents requires close monitoring and should be used judiciously to avoid adverse effects.
Extracorporeal membrane oxygenation (ECMO) may be used as a rescue therapy in refractory cases.